0001225208-11-010485.txt : 20110330 0001225208-11-010485.hdr.sgml : 20110330 20110330184440 ACCESSION NUMBER: 0001225208-11-010485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110328 FILED AS OF DATE: 20110330 DATE AS OF CHANGE: 20110330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEILAND JOHN H CENTRAL INDEX KEY: 0001204663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 11723375 MAIL ADDRESS: STREET 1: C/O C.R BARD INC STREET 2: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0303 4 2011-03-28 0000009892 BARD C R INC /NJ/ BCR 0001204663 WEILAND JOHN H C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 1 President and COO Common Stock 2011-03-28 4 M 0 96296.0000 54.9650 A 288082.2900 D Common Stock 2011-03-28 4 S 0 96296.0000 96.8690 D 191786.2900 D Common Stock 2011-03-29 4 M 0 13424.0000 54.9650 A 205210.2900 D Common Stock 2011-03-29 4 S 0 13424.0000 96.9747 D 191786.2900 D Common Stock 5109.5270 I 401(k) Plan Option (Right to Buy) 54.9650 2011-03-28 4 M 0 96296.0000 0.0000 D 2014-07-14 Common Stock 96296.0000 13424.0000 D Option (Right to Buy) 54.9650 2011-03-29 4 M 0 13424.0000 0.0000 D 2014-07-14 Common Stock 13424.0000 0.0000 D Option exercises and sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $96.49 to $97.46. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $96.80 to $97.26. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 46.652 shares acquired under the Company's 401(k) Plan from February 28, 2011 to March 18, 2011. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan. Options fully vested in accordance with schedule upon achievement of certain performance criteria. Myra McGinley, Attorney-in-Fact 2011-03-30